Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1995-06-07
1998-08-18
Smith, Lynette F.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
435 691, 435 693, 4353201, 4241881, 530395, A61K 3921, C12P 2106, C12N 1500, C07K 100
Patent
active
057955778
ABSTRACT:
This invention relates to an immunogenic composition comprising a viral vector. The genome of the viral vector comprises a functional origin of replication of a poxvirus, a DNA fragment encoding a non-cleavable gp160, a DNA fragment encoding a signal peptide, and a promoter for expressing DNA fragments in mammalian cells.
REFERENCES:
patent: 4745051 (1988-05-01), Smith et al.
Bialy, BioTechnology, 4, 166 (1986).
Chakrabarti et al., Nature, 320, 535-537 (1986).
Hu et al., Nature, 320, 537-540 (1986).
Kieny et al., BioTechnology, 4, 790-795 (1986).
Sanchez-Pescador et al., Science, 227, 484-492 (1985).
Lasky et al., Science, 233, 209-212 (1986).
Fisher et al., Science, 233, 655-659 (1986).
Kieny et al., Nature, 312, 163-166 (1984).
An English Translation of the relevant pages of EP 0 094 887.
Anilionis et al., Comp. Immun. Microbiol. Infect. Div., 5, 27-32 (1982).
Muesing et al., Nature, 313, 450-458 (1985).
Nagai et al., Virology, 12, 494-508 (1976).
Crowl et al., Cell, 41, 979-986 (1985).
Bosch et al., Virology, 113, 725-735 (1981).
Brown, Washington Post Newspaper, "Aids Vaccine Trials Viewed with Caution", Jun. 10, 1993.
Greene, Scientific American, Sep. 1993, pp. 99-105.
Cohen, Science, 262, 980-981 (1993).
Palker, T.J. et al., J. Immunol. 142:971-978 (1989).
Patarca, R. and Haseltine, W. A., Nature 309:728 (1984).
Poiesz, B.J. et al., Proc. Natl. Acad. Sci. USA 77:7415-7419 (1980).
Poiesz, B.J. et al., Nature 294:268-271 (1981).
Ralph, R.K., Nature 311:515 (1984).
Ralston, S. et al., J. Biol. Chem. 264,28:16343-16346 (1989).
Robert-Guroff, M. et al., J. Exper. Med. 154:1957-1964 (1981).
Robert-Guroff, M. et al., J. Exper. Med. 157:248-258 (1983).
Robert-Guroff, M. and Shepard, E., J. Virology 53,1:214-220 (1985).
Samuel, K.P. et al., Science 226:1094-1097 (1984).
Saxinger, W. et al., Science (Sep. 28) 225:1473-1476 (1984).
Schupbach, J. et al., Science 224:607-610 (1984).
Seiki, M. et al., Proc. Natl. Acad. Sci. USA 80:3618-3622 (1983).
Shimoyama, M. et al., Jpn. J. Clin. Oncol. 12,1:109-116 (1982).
Slamon, D.J. et al., Science 226:61-65 (1984).
Sodroski, J. et al., Science 225:421-424 (1984).
Sugamura, K. et al., J. Immun. 132,6:3180-3184 (1984).
Tanaka, Y. et al., Int. J. Cancer 36:549-555 (1985).
Tanaka, Y. et al., Int. J. Cancer 46:675-681 (1990).
Viscidi, R.P. et al., J. AIDS 4:1190-1198 (1991).
Wang, J. J. G. et al., Proc. Natl. Acad. Sci. USA 83:6159-6163 (1986).
Washitani et al., Int. J. Cancer 49:173-177 (1991).
Wiktor S.Z. et al., Lancet 335:1533 (1990).
Wiktor S.Z. et al., Lancet 338:512-513 (1991).
Williams, A. E. et al., Science 240:643-646 (1988).
Williams, A. E. et al., MMWR 39,50:915-924 (1990).
Yoshida, M. et al., Proc. Natl. Acad. Sci. USA 79:2031-2035 (1982).
Girard Marc
Hobson Simon Wain
Kieny Marie-Paule
LeCocq Jean-Pierre
Montagnier Luc
Institut Pasteur
Smith Lynette F.
Transgene S.A.
LandOfFree
Viral vector coding for a glycoprotein of the virus responsible does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Viral vector coding for a glycoprotein of the virus responsible , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Viral vector coding for a glycoprotein of the virus responsible will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1112571